SEC Form 4 · accession 0001209191-18-036531
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Gorlin
Director
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 8:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2018 | S | 28,925 | $3.7455 | D | 372,251 | I | By spouse |
| Common StockF2 | Jun 6, 2018 | S | 23,574 | $3.7869 | D | 348,677 | I | By spouse |
| Common StockF3 | Jun 7, 2018 | S | 26,957 | $3.6582 | D | 321,720 | I | By spouse |
| Common Stock | holding | — | — | — | 246,280 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average share price of an aggregate total of 28,925 shares sold in the price range of $3.74 to $3.79 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Represents the weighted average share price of an aggregate total of 23,574 shares sold in the price range of $3.77 to $3.815 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Represents the weighted average share price of an aggregate total of 26,957 shares sold in the price range of $3.62 to $3.75 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.